Global Pomalidomide API Market Research Report 2025

Publication ID:

PB501254476

Publication Date:

February 5, 2025

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Pomalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pomalidomide(CAS锛�19171-19-8) is a derivative of thalidomide marketed by Celgene.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pomalidomide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide API.
The Pomalidomide API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pomalidomide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan
Dr. Reddy's Laboratories
Hetero Drugs
Mac-Chem Products (India) Pvt.Ltd
Shilpa Medicare
Veranova
Natco Pharma Limited
Mehta API
Symed Labs Limited
Hangzhou Longshine Bio-Tech
Guangzhou Tosun Pharmaceutical
Sumar Biotech
Deva Holding AS
by Type
Above 98 %
Above 99 %
by Application
Capsules
Others
Production by Region
North America
China
India
Mid East & Africa
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pomalidomide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pomalidomide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pomalidomide API Market Overview
1.1 Product Definition
1.2 Pomalidomide API by Type
1.2.1 Global Pomalidomide API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Pomalidomide API by Application
1.3.1 Global Pomalidomide API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Capsules
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pomalidomide API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pomalidomide API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pomalidomide API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pomalidomide API Production Market Share by Manufacturers (2020-2025)
2.2 Global Pomalidomide API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pomalidomide API, Industry Ranking, 2023 VS 2024
2.4 Global Pomalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pomalidomide API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pomalidomide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pomalidomide API, Product Offered and Application
2.8 Global Key Manufacturers of Pomalidomide API, Date of Enter into This Industry
2.9 Pomalidomide API Market Competitive Situation and Trends
2.9.1 Pomalidomide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pomalidomide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pomalidomide API Production by Region
3.1 Global Pomalidomide API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pomalidomide API Production Value by Region (2020-2031)
3.2.1 Global Pomalidomide API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pomalidomide API by Region (2026-2031)
3.3 Global Pomalidomide API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pomalidomide API Production Volume by Region (2020-2031)
3.4.1 Global Pomalidomide API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pomalidomide API by Region (2026-2031)
3.5 Global Pomalidomide API Market Price Analysis by Region (2020-2025)
3.6 Global Pomalidomide API Production and Value, Year-over-Year Growth
3.6.1 North America Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.3 India Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Mid East & Africa Pomalidomide API Production Value Estimates and Forecasts (2020-2031)
4 Pomalidomide API Consumption by Region
4.1 Global Pomalidomide API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pomalidomide API Consumption by Region (2020-2031)
4.2.1 Global Pomalidomide API Consumption by Region (2020-2025)
4.2.2 Global Pomalidomide API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pomalidomide API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pomalidomide API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pomalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pomalidomide API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pomalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pomalidomide API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pomalidomide API Production by Type (2020-2031)
5.1.1 Global Pomalidomide API Production by Type (2020-2025)
5.1.2 Global Pomalidomide API Production by Type (2026-2031)
5.1.3 Global Pomalidomide API Production Market Share by Type (2020-2031)
5.2 Global Pomalidomide API Production Value by Type (2020-2031)
5.2.1 Global Pomalidomide API Production Value by Type (2020-2025)
5.2.2 Global Pomalidomide API Production Value by Type (2026-2031)
5.2.3 Global Pomalidomide API Production Value Market Share by Type (2020-2031)
5.3 Global Pomalidomide API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pomalidomide API Production by Application (2020-2031)
6.1.1 Global Pomalidomide API Production by Application (2020-2025)
6.1.2 Global Pomalidomide API Production by Application (2026-2031)
6.1.3 Global Pomalidomide API Production Market Share by Application (2020-2031)
6.2 Global Pomalidomide API Production Value by Application (2020-2031)
6.2.1 Global Pomalidomide API Production Value by Application (2020-2025)
6.2.2 Global Pomalidomide API Production Value by Application (2026-2031)
6.2.3 Global Pomalidomide API Production Value Market Share by Application (2020-2031)
6.3 Global Pomalidomide API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Pomalidomide API Company Information
7.1.2 Mylan Pomalidomide API Product Portfolio
7.1.3 Mylan Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Pomalidomide API Company Information
7.2.2 Dr. Reddy's Laboratories Pomalidomide API Product Portfolio
7.2.3 Dr. Reddy's Laboratories Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.3 Hetero Drugs
7.3.1 Hetero Drugs Pomalidomide API Company Information
7.3.2 Hetero Drugs Pomalidomide API Product Portfolio
7.3.3 Hetero Drugs Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hetero Drugs Main Business and Markets Served
7.3.5 Hetero Drugs Recent Developments/Updates
7.4 Mac-Chem Products (India) Pvt.Ltd
7.4.1 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Company Information
7.4.2 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolio
7.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served
7.4.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
7.5 Shilpa Medicare
7.5.1 Shilpa Medicare Pomalidomide API Company Information
7.5.2 Shilpa Medicare Pomalidomide API Product Portfolio
7.5.3 Shilpa Medicare Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shilpa Medicare Main Business and Markets Served
7.5.5 Shilpa Medicare Recent Developments/Updates
7.6 Veranova
7.6.1 Veranova Pomalidomide API Company Information
7.6.2 Veranova Pomalidomide API Product Portfolio
7.6.3 Veranova Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Veranova Main Business and Markets Served
7.6.5 Veranova Recent Developments/Updates
7.7 Natco Pharma Limited
7.7.1 Natco Pharma Limited Pomalidomide API Company Information
7.7.2 Natco Pharma Limited Pomalidomide API Product Portfolio
7.7.3 Natco Pharma Limited Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Natco Pharma Limited Main Business and Markets Served
7.7.5 Natco Pharma Limited Recent Developments/Updates
7.8 Mehta API
7.8.1 Mehta API Pomalidomide API Company Information
7.8.2 Mehta API Pomalidomide API Product Portfolio
7.8.3 Mehta API Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Mehta API Main Business and Markets Served
7.8.5 Mehta API Recent Developments/Updates
7.9 Symed Labs Limited
7.9.1 Symed Labs Limited Pomalidomide API Company Information
7.9.2 Symed Labs Limited Pomalidomide API Product Portfolio
7.9.3 Symed Labs Limited Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Symed Labs Limited Main Business and Markets Served
7.9.5 Symed Labs Limited Recent Developments/Updates
7.10 Hangzhou Longshine Bio-Tech
7.10.1 Hangzhou Longshine Bio-Tech Pomalidomide API Company Information
7.10.2 Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolio
7.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.10.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.11 Guangzhou Tosun Pharmaceutical
7.11.1 Guangzhou Tosun Pharmaceutical Pomalidomide API Company Information
7.11.2 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolio
7.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.11.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.12 Sumar Biotech
7.12.1 Sumar Biotech Pomalidomide API Company Information
7.12.2 Sumar Biotech Pomalidomide API Product Portfolio
7.12.3 Sumar Biotech Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Sumar Biotech Main Business and Markets Served
7.12.5 Sumar Biotech Recent Developments/Updates
7.13 Deva Holding AS
7.13.1 Deva Holding AS Pomalidomide API Company Information
7.13.2 Deva Holding AS Pomalidomide API Product Portfolio
7.13.3 Deva Holding AS Pomalidomide API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Deva Holding AS Main Business and Markets Served
7.13.5 Deva Holding AS Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pomalidomide API Industry Chain Analysis
8.2 Pomalidomide API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pomalidomide API Production Mode & Process Analysis
8.4 Pomalidomide API Sales and Marketing
8.4.1 Pomalidomide API Sales Channels
8.4.2 Pomalidomide API Distributors
8.5 Pomalidomide API Customer Analysis
9 Pomalidomide API Market Dynamics
9.1 Pomalidomide API Industry Trends
9.2 Pomalidomide API Market Drivers
9.3 Pomalidomide API Market Challenges
9.4 Pomalidomide API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Mylan
Dr. Reddy's Laboratories
Hetero Drugs
Mac-Chem Products (India) Pvt.Ltd
Shilpa Medicare
Veranova
Natco Pharma Limited
Mehta API
Symed Labs Limited
Hangzhou Longshine Bio-Tech
Guangzhou Tosun Pharmaceutical
Sumar Biotech
Deva Holding AS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂